47,306 Shares in Astera Labs, Inc. $ALAB Acquired by Temasek Holdings Private Ltd

Temasek Holdings Private Ltd bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 47,306 shares of the company’s stock, valued at approximately $7,870,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Assetmark Inc. grew its stake in shares of Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares in the last quarter. Smartleaf Asset Management LLC boosted its position in shares of Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares during the period. Hilltop National Bank raised its stake in Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after purchasing an additional 100 shares in the last quarter. Aventura Private Wealth LLC acquired a new position in Astera Labs during the fourth quarter worth about $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in Astera Labs during the fourth quarter worth about $33,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently commented on ALAB shares. TD Cowen upped their target price on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a report on Wednesday, May 6th. Susquehanna increased their target price on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. Royal Bank Of Canada raised their target price on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. JPMorgan Chase & Co. increased their target price on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. Finally, Needham & Company LLC raised their target price on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Insiders Place Their Bets

In other news, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This represents a 7.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $364.35, for a total value of $1,277,046.75. Following the transaction, the director directly owned 60,134 shares of the company’s stock, valued at approximately $21,909,822.90. The trade was a 5.51% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 2,161,256 shares of company stock valued at $459,844,296. Company insiders own 10.40% of the company’s stock.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $389.20 on Tuesday. Astera Labs, Inc. has a one year low of $84.78 and a one year high of $398.13. The stock has a market capitalization of $66.71 billion, a P/E ratio of 262.97, a price-to-earnings-growth ratio of 4.86 and a beta of 3.94. The business’s 50 day simple moving average is $242.61 and its two-hundred day simple moving average is $180.88.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s revenue was up 93.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.